deoxycytidine and Scleroderma, Localized

deoxycytidine has been researched along with Scleroderma, Localized in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Haes, P; Morren, MA; Noë, E; Van Cutsem, E; Van den Oord, JJ; Verhulst, L; Verslype, C	1
Huang, WW; McGregor, S; Nyckowski, T	1
Hengge, UR; Marini, A	1
Hwang, SJ; Kim, BS; Kim, HJ; Kim, YJ; Lee, SD; Nam, SH	1
Fariña, MC; Haro, R; Requena, L; Trindade, F	1

Reviews

1 review(s) available for deoxycytidine and Scleroderma, Localized

Article	Year
Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature. International journal of dermatology, 2018, Volume: 57, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Scleroderma, Localized	2018

Article

Year

Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature.

International journal of dermatology, 2018, Volume: 57, Issue:9

Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Scleroderma, Localized

2018

Other Studies

4 other study(ies) available for deoxycytidine and Scleroderma, Localized

Article	Year
A case of gemcitabine-related acute lipodermatosclerosis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:5 Topics: Acute Disease; Antimetabolites, Antineoplastic; Deoxycytidine; Dermatitis; Female; Gemcitabine; Humans; Middle Aged; Pancreatic Neoplasms; Scleroderma, Localized	2019
[Hand-foot syndrome with capecitabine therapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2007, Volume: 58, Issue:6 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Esophageal Neoplasms; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Localized; Syndrome	2007
Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report. The Korean journal of internal medicine, 2007, Volume: 22, Issue:2 Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Male; Risk Factors; Scleroderma, Localized	2007
Hand-foot syndrome with sclerodactyly-like changes in a patient treated with capecitabine. The American Journal of dermatopathology, 2008, Volume: 30, Issue:2 Topics: Adenocarcinoma; Administration, Oral; Biopsy, Needle; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Fluorouracil; Follow-Up Studies; Hand Dermatoses; Humans; Immunohistochemistry; Liver Neoplasms; Male; Middle Aged; Scleroderma, Localized; Severity of Illness Index; Sigmoid Neoplasms; Syndrome	2008